The Latin America, Middle East and Africa Chronic Disease Management Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).
In order to obtain services, health plans typically enter into contracts with vendors, also referred to as disease management organizations. But, some people decide to run the application themselves. Improvements in self-care behaviours and a decrease in the usage of different health care services, such as hospital admissions and ER visits, have been achieved by several disease management programmes. Due to this, costs for certain groups with chronic illnesses have gone down.
Because they are committed to providing complete, coordinated care, managed care organizations are in a good position to practise disease management. They put a strong emphasis on enhancing the health of whole patient populations, effectively utilize the resources at hand, and are held responsible for the calibre of their medical services by patients, customers, and regulators. Education for patients and healthcare professionals, ambulatory care, home health care, acute care, and nursing home services are all integrated by managed care organizations. Better health results are produced as a result of higher patient care continuity.
The United Arab Emirates has transformed into a prosperous, modern nation with a Western way of life from a developing nation with a sizable nomadic population. Certainly, this economic development has given UAE inhabitants social benefits and possibilities, including a high and rising life expectancy. But, a serious issue with chronic diseases, notably cardiovascular risk associated with obesity, has been exacerbated by fast industrialization and urbanization. As a result, the Health Authority of Abu Dhabi has greatly improved its data systems to more accurately determine the starting point and gauge the results of focused interventions.
The Brazil market dominated the LAMEA Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $177.7 million by 2028.The Argentina market is experiencing a CAGR of 14.8% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.9% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Chronic Disease Management Market is Predict to reach $9.9 Billion by 2028, at a CAGR of 11.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
By End User
- Healthcare Providers
- Healthcare Payers
- Others
By Disease Type
- Diabetes
- Cardiovascular diseases
- Asthma
- Chronic obstructive pulmonary disorders
- Cancer
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Infosys Limited
- ExlService Holdings, Inc.
- Health Catalyst, Inc.
- AllScripts Healthcare Solutions, Inc.
- Koninklijke Philips N.V.
- Cognizant Technology Solutions Corporation
- Casenet, LLC
- Cedar Gate Technologies
- Clinical Excellence, Inc.
- Altruista Health, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Chronic Disease Management Market, by Type
1.4.2 LAMEA Chronic Disease Management Market, by End User
1.4.3 LAMEA Chronic Disease Management Market, by Disease Type
1.4.4 LAMEA Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
Chapter 4. LAMEA Chronic Disease Management Market by Type
4.1 LAMEA Solutions Market by Country
4.2 LAMEA Services Market by Country
Chapter 5. LAMEA Chronic Disease Management Market by End User
5.1 LAMEA Healthcare Providers Market by Country
5.2 LAMEA Healthcare Payers Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Chronic Disease Management Market by Disease Type
6.1 LAMEA Diabetes Market by Country
6.2 LAMEA Cardiovascular diseases Market by Country
6.3 LAMEA Asthma Market by Country
6.4 LAMEA Chronic obstructive pulmonary disorders Market by Country
6.5 LAMEA Cancer Market by Country
6.6 LAMEA Others Market by Country
Chapter 7. LAMEA Chronic Disease Management Market by Country
7.1 Brazil Chronic Disease Management Market
7.1.1 Brazil Chronic Disease Management Market by Type
7.1.2 Brazil Chronic Disease Management Market by End User
7.1.3 Brazil Chronic Disease Management Market by Disease Type
7.2 Argentina Chronic Disease Management Market
7.2.1 Argentina Chronic Disease Management Market by Type
7.2.2 Argentina Chronic Disease Management Market by End User
7.2.3 Argentina Chronic Disease Management Market by Disease Type
7.3 UAE Chronic Disease Management Market
7.3.1 UAE Chronic Disease Management Market by Type
7.3.2 UAE Chronic Disease Management Market by End User
7.3.3 UAE Chronic Disease Management Market by Disease Type
7.4 Saudi Arabia Chronic Disease Management Market
7.4.1 Saudi Arabia Chronic Disease Management Market by Type
7.4.2 Saudi Arabia Chronic Disease Management Market by End User
7.4.3 Saudi Arabia Chronic Disease Management Market by Disease Type
7.5 South Africa Chronic Disease Management Market
7.5.1 South Africa Chronic Disease Management Market by Type
7.5.2 South Africa Chronic Disease Management Market by End User
7.5.3 South Africa Chronic Disease Management Market by Disease Type
7.6 Nigeria Chronic Disease Management Market
7.6.1 Nigeria Chronic Disease Management Market by Type
7.6.2 Nigeria Chronic Disease Management Market by End User
7.6.3 Nigeria Chronic Disease Management Market by Disease Type
7.7 Rest of LAMEA Chronic Disease Management Market
7.7.1 Rest of LAMEA Chronic Disease Management Market by Type
7.7.2 Rest of LAMEA Chronic Disease Management Market by End User
7.7.3 Rest of LAMEA Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
TABLE 1 LAMEA Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Chronic Disease Management Market
TABLE 4 Product Launches And Product Expansions – Chronic Disease Management Market
TABLE 5 Acquisition and Mergers – Chronic Disease Management Market
TABLE 6 Approvals and Trials – Chronic Disease Management Market
TABLE 7 LAMEA Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 8 LAMEA Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 9 LAMEA Solutions Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Solutions Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 14 LAMEA Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 15 LAMEA Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 22 LAMEA Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 23 LAMEA Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Asthma Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Asthma Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 37 Brazil Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 38 Brazil Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 39 Brazil Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 40 Brazil Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 41 Brazil Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 42 Brazil Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 43 Brazil Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 44 Brazil Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 45 Argentina Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 46 Argentina Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 47 Argentina Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 48 Argentina Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 49 Argentina Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 50 Argentina Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 51 Argentina Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 52 Argentina Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 53 UAE Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 54 UAE Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 55 UAE Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 56 UAE Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 57 UAE Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 58 UAE Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 59 UAE Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 60 UAE Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 65 Saudi Arabia Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 66 Saudi Arabia Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 67 Saudi Arabia Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 68 Saudi Arabia Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 69 South Africa Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 70 South Africa Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 71 South Africa Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 72 South Africa Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 73 South Africa Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 74 South Africa Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 75 South Africa Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 76 South Africa Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 77 Nigeria Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 78 Nigeria Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 79 Nigeria Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 80 Nigeria Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 81 Nigeria Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 82 Nigeria Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 83 Nigeria Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 84 Nigeria Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 87 Rest of LAMEA Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 88 Rest of LAMEA Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 89 Rest of LAMEA Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 90 Rest of LAMEA Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 91 Rest of LAMEA Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 92 Rest of LAMEA Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 93 Key Information – Infosys Limited
TABLE 94 Key Information – ExlService Holdings, Inc.
TABLE 95 Key Information – Health Catalyst, Inc.
TABLE 96 Key Information – AllScripts Healthcare Solutions, Inc.
TABLE 97 Key Information – Koninklijke Philips N.V.
TABLE 98 Key Information – Cognizant Technology Solutions Corporation
TABLE 99 Key Information – Casenet, LLC
TABLE 100 Key Information – Cedar Gate Technologies
TABLE 101 Key Information – Clinical Excellence, Inc.
TABLE 102 Key Information – Altruista Health, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
FIG 5 SWOT Analysis: Infosys Limited
FIG 6 Recent strategies and developments: Koninklijke Philips N.V.
FIG 7 Swot analysis: cognizant technology solutions corporation